Early Adoption and Outcomes of Ibrutinib As Treatment for Older Patients with Chronic Lymphocytic Leukemia (CLL): A Population-Based Study
Year: 2019
Type: conference-abstract
Source: Blood
Institutions: Brown University, Dana-Farber Cancer Institute, Lifespan
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2989897460
